Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Autism in Children

Author(s):  Cave Stephanie

Issue:  Jan/Feb 2001 - Compounding for Pediatric Patients
View All Articles in Issue

Page(s):  18-19

Autism in Children Page 1
Autism in Children Page 2

Download in electronic PDF format for $75

Abstract:  Autism incorporates most of the characteristics of a metabolic disorder. In this discussion, the author focuses on biochemical markers, causes of autism and treatments.

Related Keywords: autism, autistic, autistic children

Related Categories: MENTAL HEALTH, PEDIATRICS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Autism in Children
Cave Stephanie
Jan/Feb 2001
Pg. 18-19

Topical Secretin for the Treatment of Autism
King Erin
, Toney Steve
Nov/Dec 2001
Pg. 436-437

Unlocking Autism: Is Compounding the Key?
Vail Jane
Nov/Dec 2005
Pg. 413-420

PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Neurander James A
Nov/Dec 2005
Pg. 487-488

Compounding Naltrexone for the Treatment of Autism
Wynn Tom
, Brunetti Sarah
Jul/Aug 2009
Pg. 296-299

Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
Sep/Oct 2006
Pg. 390

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
Sep/Oct 2018
Pg. 358-366

Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Cho Sung Kyung
, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2020
Pg. 367-369

Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
May/Jun 2016
Pg. 247-249

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
Sep/Oct 2017
Pg. 364-370

Sevelamer Suspension in Children with End-Stage Renal Disease
McElhiney Linda F
Jan/Feb 2007
Pg. 20-24

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Developmentā€”Pediatric Formulations Initiative, Part 1
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 5-8

Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
Jan/Feb 2007
Pg. 27

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Sleepless in America: Compounding with Melatonin
Wynn Tom
, Rawlings Kate
Jan/Feb 2010
Pg. 10-13

Pediatric Health Care: An Introduction
Williams LaVonn A
Jan/Feb 2013
Pg. 6-8

Return to Top